267 related articles for article (PubMed ID: 28492501)
1. Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations.
Troisi J; Pierri L; Landolfi A; Marciano F; Bisogno A; Belmonte F; Palladino C; Guercio Nuzio S; Campiglia P; Vajro P
Nutrients; 2017 May; 9(5):. PubMed ID: 28492501
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome.
Troisi J; Belmonte F; Bisogno A; Pierri L; Colucci A; Scala G; Cavallo P; Mandato C; Di Nuzzi A; Di Michele L; Delli Bovi AP; Guercio Nuzio S; Vajro P
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30691143
[TBL] [Abstract][Full Text] [Related]
3. The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents.
Belei O; Olariu L; Dobrescu A; Marcovici T; Marginean O
J Pediatr Endocrinol Metab; 2017 Oct; 30(11):1161-1168. PubMed ID: 28988228
[TBL] [Abstract][Full Text] [Related]
4. Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.
Miccheli A; Capuani G; Marini F; Tomassini A; Praticò G; Ceccarelli S; Gnani D; Baviera G; Alisi A; Putignani L; Nobili V
Int J Obes (Lond); 2015 Jul; 39(7):1118-25. PubMed ID: 25809828
[TBL] [Abstract][Full Text] [Related]
5. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
6. Non-Alcoholic Fatty Liver Disease in Overweight Children: Role of Fructose Intake and Dietary Pattern.
Nier A; Brandt A; Conzelmann IB; Özel Y; Bergheim I
Nutrients; 2018 Sep; 10(9):. PubMed ID: 30235828
[TBL] [Abstract][Full Text] [Related]
7. Integrative metabolomics highlights gut microbiota metabolites as novel NAFLD-related candidate biomarkers in children.
Luo J; Luo M; Kaminga AC; Wei J; Dai W; Peng Y; Zhao K; Duan Y; Xiao X; Ouyang S; Yao Z; Liu Y; Pan X
Microbiol Spectr; 2024 Apr; 12(4):e0523022. PubMed ID: 38445874
[TBL] [Abstract][Full Text] [Related]
8. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
Clemente MG; Mandato C; Poeta M; Vajro P
World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
[TBL] [Abstract][Full Text] [Related]
9. Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement.
Guercio Nuzio S; Di Stasi M; Pierri L; Troisi J; Poeta M; Bisogno A; Belmonte F; Tripodi M; Di Salvio D; Massa G; Savastano R; Cavallo P; Boffardi M; Ziegenhardt D; Bergheim I; Mandato C; Vajro P
Pediatr Obes; 2017 Dec; 12(6):446-452. PubMed ID: 27350543
[TBL] [Abstract][Full Text] [Related]
10. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease.
Dong S; Zhan ZY; Cao HY; Wu C; Bian YQ; Li JY; Cheng GH; Liu P; Sun MY
World J Gastroenterol; 2017 Apr; 23(15):2771-2784. PubMed ID: 28487615
[TBL] [Abstract][Full Text] [Related]
11. Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.
Feldman A; Eder SK; Felder TK; Paulweber B; Zandanell S; Stechemesser L; Schranz M; Strebinger G; Huber-Schönauer U; Niederseer D; Patsch W; Weghuber D; Tevini J; Datz C; Aigner E
Diabetes Metab; 2019 Apr; 45(2):132-139. PubMed ID: 30266576
[TBL] [Abstract][Full Text] [Related]
12. Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Gudan A; Kozłowska-Petriczko K; Wunsch E; Bodnarczuk T; Stachowska E
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986052
[TBL] [Abstract][Full Text] [Related]
13. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
14. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
15. Investigation of adropin and leptin levels in pediatric obesity-related nonalcoholic fatty liver disease.
Sayın O; Tokgöz Y; Arslan N
J Pediatr Endocrinol Metab; 2014 May; 27(5-6):479-84. PubMed ID: 24468600
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
18. A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease.
Goffredo M; Santoro N; Tricò D; Giannini C; D'Adamo E; Zhao H; Peng G; Yu X; Lam TT; Pierpont B; Caprio S; Herzog RI
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28640216
[TBL] [Abstract][Full Text] [Related]
19. Association of nonalcoholic fatty liver disease with small intestine bacterial overgrowth in obese children.
Stepanov YM; Zavhorodnia NY; Yagmur VB; Lukianenko OY; Zygalo EV
Wiad Lek; 2019; 72(3):350-356. PubMed ID: 31050979
[TBL] [Abstract][Full Text] [Related]
20. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
